Senior fellow in Intensive Care medicine, Institute of Global Health Innovation, Imperial College London.Wellcome Trust clinical research fellow in health informatics and translational AI.
Ville-Petteri Mäkinen's main focus is on the molecular determinants of human phenotypes and their significance to chronic morbidity such as dementia, obesity, diabetes and heart disease later in life. He holds an EMBL Australia Group Leader position in the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide, and he is affiliated with the Australian Center for Precision Medicine at the University of South Australia and the Center of Life Course Health Research at the University of Oulu. In 2014, he was appointed to the prestigious EMBL Australia position at SAHMRI, where he is currently leading a cross-disciplinary research group that focuses on the translation of epidemiological results on age-associated diseases into wet lab hypotheses and vice versa.
January 24,2022, 5:00 – 6:00 PM EST.
5:00 – 5:05: Opening remarks
5:05 – 5:20: A real-time dashboard to track global clinical artificial intelligence research: Dr. Joe Zhang
5:20 – 5:45: Machine learning in medicine: the TEHAI framework: Associate Professor Ville-Petteri Mäkinen
5:45 – 6:00 Q&A